JPS4975552A - - Google Patents
Info
- Publication number
- JPS4975552A JPS4975552A JP11557672A JP11557672A JPS4975552A JP S4975552 A JPS4975552 A JP S4975552A JP 11557672 A JP11557672 A JP 11557672A JP 11557672 A JP11557672 A JP 11557672A JP S4975552 A JPS4975552 A JP S4975552A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11557672A JPS4975552A (fr) | 1972-11-20 | 1972-11-20 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11557672A JPS4975552A (fr) | 1972-11-20 | 1972-11-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS4975552A true JPS4975552A (fr) | 1974-07-20 |
Family
ID=14665980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11557672A Pending JPS4975552A (fr) | 1972-11-20 | 1972-11-20 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS4975552A (fr) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998051662A3 (fr) * | 1997-05-14 | 2000-03-02 | Atherogenics Inc | Composes et methodes d'inhibition de l'expression de vcam-1 |
| US6852878B2 (en) | 1998-05-14 | 2005-02-08 | Atherogenics, Inc. | Thioketals and thioethers for inhibiting the expression of VCAM-1 |
| US7087645B2 (en) | 1997-05-14 | 2006-08-08 | Atherogenics, Inc. | Compounds and methods for treating transplant rejection |
| EP1695959A1 (fr) * | 1997-05-14 | 2006-08-30 | Atherogenics, Inc. | Composes et methodes d'inhibition de l'expression de VCAM-1 |
| US8252840B2 (en) | 2007-03-26 | 2012-08-28 | Salutria Pharmaceuticals Llc | Methods of derivatives of probucol for the treatment of type II diabetes |
-
1972
- 1972-11-20 JP JP11557672A patent/JPS4975552A/ja active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998051662A3 (fr) * | 1997-05-14 | 2000-03-02 | Atherogenics Inc | Composes et methodes d'inhibition de l'expression de vcam-1 |
| US7087645B2 (en) | 1997-05-14 | 2006-08-08 | Atherogenics, Inc. | Compounds and methods for treating transplant rejection |
| EP1695959A1 (fr) * | 1997-05-14 | 2006-08-30 | Atherogenics, Inc. | Composes et methodes d'inhibition de l'expression de VCAM-1 |
| US7189870B2 (en) | 1997-05-14 | 2007-03-13 | Atherogenic, Inc. | Compounds and methods for the inhibition of the expression of VCAM-1 |
| EA009370B1 (ru) * | 1997-05-14 | 2007-12-28 | Атеродженикс, Инк. | Соединение и фармацевтическая композиция для ингибирования экспрессии vcam-1 |
| EA009987B1 (ru) * | 1997-05-14 | 2008-04-28 | Атеродженикс, Инк. | Производные пробукола для лечения заболеваний, опосредованных vcam-1 |
| US6852878B2 (en) | 1998-05-14 | 2005-02-08 | Atherogenics, Inc. | Thioketals and thioethers for inhibiting the expression of VCAM-1 |
| US8252840B2 (en) | 2007-03-26 | 2012-08-28 | Salutria Pharmaceuticals Llc | Methods of derivatives of probucol for the treatment of type II diabetes |